Genomic and immune profiling of pre-invasive lung adenocarcinoma
- PMID: 31784532
- PMCID: PMC6884501
- DOI: 10.1038/s41467-019-13460-3
Genomic and immune profiling of pre-invasive lung adenocarcinoma
Abstract
Adenocarcinoma in situ and minimally invasive adenocarcinoma are the pre-invasive forms of lung adenocarcinoma. The genomic and immune profiles of these lesions are poorly understood. Here we report exome and transcriptome sequencing of 98 lung adenocarcinoma precursor lesions and 99 invasive adenocarcinomas. We have identified EGFR, RBM10, BRAF, ERBB2, TP53, KRAS, MAP2K1 and MET as significantly mutated genes in the pre/minimally invasive group. Classes of genome alterations that increase in frequency during the progression to malignancy are revealed. These include mutations in TP53, arm-level copy number alterations, and HLA loss of heterozygosity. Immune infiltration is correlated with copy number alterations of chromosome arm 6p, suggesting a link between arm-level events and the tumor immune environment.
Conflict of interest statement
M.M. is the scientific advisory board chair of OrigiMed; an inventor of a patent licensed to LabCorp for
Figures
References
-
- Siegel RL, et al. Cancer statistics, 2018. CA Cancer J. Clin. 2018;68:7–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
